Phenotypic plasticity has emerged as a major contributor to intra-tumoral heterogeneity and
treatment resistance in cancer. Increasing evidence shows that glioblastoma (GBM) cells …

Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

The identity and unique capacity of cancer stem cells (CSC) to drive tumor growth and
resistance have been challenged in brain tumors. Here we report that cells expressing CSC …

Cancer stem cells (CSCs) have been identified as rare cell populations in many cancers,
including leukemia and solid tumors. Accumulating evidence has suggested that CSCs are …

Combination therapy is increasingly becoming the cornerstone of current day antitumor
therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival …

Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5‐
year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique …

Glioblastoma stem cells (GSCs) are subpopulations of tumor-initiating cells responsible for
glioblastoma (GBM) tumorigenesis and recurrence. Dual inhibition of vascular endothelium …

Cancer stem cells (CSCs) or cancer initiating cells (CICs) maintain self-renewal and
multilineage differentiation properties of various tumors, as well as the cellular heterogeneity …

Glioblastoma multiforme (GBM) is the most lethal primary brain tumor characterized by high
cellular and molecular heterogeneity, hypervascularization, and innate drug resistance …

Owing to the strong absorption of water in the near-infrared (NIR) region near 1.0 μm, this
wavelength is considered unsuitable as an imaging and analytical signal in biological …